{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:39:37Z","timestamp":1789799977926,"version":"4.0.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In the combination antiretroviral therapy era, HIV-associated neurocognitive disorder (HAND) is still widespread among HIV-infected individuals. However, there is no effective treatment for HAND, and the exact pathogenic mechanism of HAND remains unknown. This paper aims to provide a reference for further exploration in the field of HAND research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used CiteSpace software to collect 3057 articles related to HAND in the Web of Science Core Collection for comprehensive analysis. Betweenness centrality, count, and burst values were used as indicators in the visualization analysis, aiming to predict future new directions and cutting-edge trends.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The last decade has been the peak period of HAND research, with the most prominent contributions by authors, countries, and institutions being Grant, Igor (135), the USA (2211), and the University of California System (758), respectively. The most frequently cited article is \u201cHIV-associated neurocognitive disorders persist in the area of potent antiretroviral therapy: CHARTER Study.\u201d The hotspots in this field are \u201cneurocognitive impairment,\u201d \u201ccentral nervous system,\u201d \u201ccerebrospinal fluid,\u201d \u201cHIV-1 tat,\u201d \u201cSIV,\u201d \u201cinflammation,\u201d \u201cinfection,\u201d and \u201cpathogenesis.\u201d The current research direction of HAND is focused on exploring the pathogenic mechanism underlying HIV-associated neurocognitive impairment and potential therapeutic targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides a bibliometric visualization of HAND-related literature to gain insight into the development and frontiers of this research field. The study also provides scholars with detailed references and identifies future research directions to better promote the development of this field of research.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1478187","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:35:32Z","timestamp":1738564532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of research on HIV-associated neurocognitive disorder and emerging trends: a visualization analysis via CiteSpace"],"prefix":"10.3389","volume":"16","author":[{"given":"Tingting","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"B1","unstructured":"2024"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814364","article-title":"Genomic factors and therapeutic approaches in HIV-associated neurocognitive disorders: a comprehensive review","volume":"24","author":"Borrajo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002227","article-title":"Mental health and HIV\/AIDS: the need for an integrated response","volume":"33","author":"Remien","year":"2019","journal-title":"AIDS (London England)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit921","article-title":"Randomized trial of central nervous system\u2013targeted antiretrovirals for HIV-associated neurocognitive disorder","volume":"58","author":"Ellis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad265","article-title":"Antiretroviral therapy intensification for neurocognitive impairment in human immunodeficiency virus","volume":"77","author":"Letendre","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02771-4","article-title":"Kynurenic acid blunts a1 astrocyte activation against neurodegeneration in HIV-associated neurocognitive disorders","volume":"20","author":"Lun","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/641913","article-title":"HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities","volume":"2015","author":"Tedaldi","year":"2015","journal-title":"BioMed Res Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00879-y","article-title":"Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management","volume":"19","author":"Ellis","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1423263","article-title":"Mechanisms and treatments of methamphetamine and HIV-1 co-induced neurotoxicity: a systematic review","volume":"15","author":"Miao","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663061","article-title":"Dopamine levels induced by substance abuse alter efficacy of maraviroc and expression of ccr5 conformations on myeloid cells: implications for NeuroHIV","volume":"12","author":"Matt","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","volume":"101","author":"Chen","year":"2004","journal-title":"PANS"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/asi.20317","article-title":"Citespace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2005","journal-title":"J Am Soc Inf Sci Technol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/asi.22968","article-title":"Patterns of connections and movements in dual-map overlays: a new method of publication portfolio analysis","volume":"65","author":"Chen","year":"2013","journal-title":"J Assoc Inf Sci Technol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/asi.20317","article-title":"Citespace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"64","author":"Chen","year":"2006","journal-title":"J Am Soc Inf Sci Technol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04113-8","article-title":"Acute administration of HIV-1 tat protein drives glutamatergic alterations in a rodent model of HIV-associated neurocognitive disorders","author":"Duffy","year":"2024","journal-title":"Mol Neurobiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04173-w","article-title":"Transactivator of transcription (tat)-induced neuroinflammation as a key pathway in neuronal dysfunction: a scoping review","author":"Muvenda","year":"2024","journal-title":"Mol Neurobiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182413065","article-title":"Knowledge mapping of research on land use change and food security: a visual analysis using citespace and vosviewer","volume":"18","author":"Cheng","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2010","journal-title":"J NeuroVirology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.53","article-title":"Erratum: HIV-associated neurocognitive disorder \u2014 pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00813-2","article-title":"Cognitive impairment in people living with HIV: consensus recommendations for a new approach","volume":"19","author":"Nightingale","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011290","article-title":"Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in art-suppressed SIV+ rhesus macaques","volume":"19","author":"Douek","year":"2023","journal-title":"PLoS Pathog"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02729-6","article-title":"Cannabinoids modulate the microbiota\u2013gut\u2013brain axis in HIV\/SIV infection by reducing neuroinflammation and dysbiosis while concurrently elevating endocannabinoid and indole-3-propionate levels","volume":"20","author":"McDew-White","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012168","article-title":"Microglia and macrophages alterations in the cns during acute SIV infection: a single-cell analysis in rhesus macaques","volume":"20","author":"Ross","year":"2024","journal-title":"PLoS Pathog"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-022-01081-4","article-title":"Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment","volume":"28","author":"Ellis","year":"2022","journal-title":"J NeuroVirology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1124\/pharmrev.122.000788","article-title":"Emergence of extracellular vesicles as \u201cliquid biopsy\u201d for neurological disorders: boom or bust","volume":"76","author":"Kumar","year":"2024","journal-title":"Pharmacol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12439","article-title":"Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders","volume":"13","author":"Chemparathy","year":"2024","journal-title":"J Extracellular Vesicles"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002277","article-title":"Prevalence of HIV-associated neurocognitive disorders in the multicenter aids cohort study","volume":"86","author":"Sacktor.","year":"2015","journal-title":"Neurology"},{"key":"B32","article-title":"Neurocognitive change in the era of HIV combination antiretroviral therapy: a longitudinal charter study","author":"Heaton. Rk","year":"2014","journal-title":"Clin Infect Dis Advance Access"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre.","year":"2008","journal-title":"Arch Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000492","article-title":"Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline","volume":"82","author":"Grant.","year":"2014","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1478187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:35:36Z","timestamp":1738564536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1478187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2025.1478187"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1478187","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"article-number":"1478187"}}